About Image
Company

About Veritas Pharmaceuticals

Veritas uses its proprietary biocatalysis technology as its core strength, strictly adheres to green intelligent manufacturing standards of zero organic solvents, pure water synthesis, high yield, and non-toxic and clean processes, and stands at the forefront of the global raw material supply chain with top-notch technology and ultimate quality.

Learn More

Professional enzyme library screening platform

Rapid enzyme directed evolution technology

Self-produced high-quality coenzyme series

High-speed enzyme catalysis technology platform

Professional protein purification technology

High-density fermentation technology

Products

Liposomal Platform

Technological advantages

Why Choose Us

Pioneering green biotechnology through enzymatic synthesis and bio-catalysis. We deliver pharmaceutical-grade coenzyme factors and bioactive molecules with uncompromising quality, sustainability, and innovation — powering the future of life sciences.

Certified Quality & Compliance

Advanced R&D Platform

End-to-End Technical Support

GMP-Standard Manufacturing

Our proprietary enzymatic synthesis eliminates toxic chemical solvents entirely. Operating on a 100% aqueous reaction system, we achieve up to 99% conversion rates while drastically reducing waste discharge. This is true green chemistry — clean, non-toxic, and fully compliant with global environmental standards. From coenzyme factors to pharmaceutical intermediates, every product is manufactured with minimal ecological footprint and maximum purity.

Bio-catalysis delivers what traditional chemical synthesis cannot: exceptional product specificity, simplified purification, and purity that exceeds pharmacopeial requirements. Our enzyme-mediated processes operate under mild conditions — no extreme temperatures or pressures — delivering consistent high yields while preserving the structural integrity of sensitive bioactive molecules. The result: premium-grade NAD+, NADH, NMN, and a full spectrum of coenzyme factors trusted by nutraceutical and pharmaceutical partners worldwide.

We don't just follow industry standards — we set them. Our core invention patents include breakthrough technologies such as high-stability NMNH sustained-release micro-pellets and specialized separation equipment for ultra-pure NAD production. With continuous investment in particle size engineering, controlled-release formulation, and enzyme modification processes, Maintain Biotech stands at the forefront of next-generation biomanufacturing — turning scientific discovery into scalable, reliable products.

Size matters in bioactivity. Through precise particle-size customization and enzymatic modification, we significantly increase the solubility, dispersion, and absorption rate of our compounds — making efficacy faster and more complete. Our expertise in controlled-release formulation enables sustained-release micro-pellets that deliver prolonged, stable therapeutic action. By engineering each molecule's physical profile, we help partners transform raw actives into high-performance finished ingredients optimized for real-world bioavailability.

Blog Posts

Latest Blogs